Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT06359067
Eligibility Criteria:
Inclusion Criteria:
* Adult ≥ 18 years old
* Patients with multiple myeloma
* Patients who received at least one administration of the following therapies: teclistamab, elranatamab
Exclusion Criteria:
\- Patients opposed to the collection of their personal data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06359067
Study Brief:
Protocol Section:
NCT06359067